CDH5 and neoplasm: VEGF-C also engages its lymphatic endothelial targets, leading to reduced expression of vascular endothelial cadherin (CD144) and disruption of the endothelial barrier, thereby facilitating tumor cell entry into lymphatic vessels 152.